• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Emergency

Intravenous fluid restriction does not improve septic shock outcomes

byBryant LimandKiera Liblik
June 27, 2022
in Emergency, Infectious Disease
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. There was no significant difference in mortality among septic shock patients in the intensive care unit (ICU) between standard and restricted intravenous (IV) fluid treatment.

2. There were no significant differences in the incidence of serious adverse events between standard and restricted intravenous fluid treatment.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Early and aggressive fluid resuscitation is known to improve survival in patients with septic shock. Yet, excessive fluid administration following initial resuscitation could lead to edema and organ damage. Currently, there are no guidelines for using restrictive or standard IV fluid strategies in patients with septic shock after initial resuscitation due to a paucity of data on their comparative outcomes. The present randomized trial evaluated adult patient mortality and adverse events of restriction and standard IV fluid strategies for septic shock patients in the ICU. Patients were followed for 90 days after starting treatment. There were no significant differences in mortality at 90 days between standard and restricted strategies. The incidence of serious adverse events was also not significantly different between groups. However, patient recruitment was limited to study sites in European countries, which can reduce generalizability to other populations. Violations in IV fluid protocol (21.5% and 13% in restrictive- and standard-fluid groups respectively) could also affect patient and study outcomes.

Click to read the study in NEJM

In-Depth [randomized controlled trial]: In the present study, ICU patients over the age of 18 with septic shock onset within 12 hours of screening (n=1,554) were randomly assigned to receive the standard or restrictive IV fluid therapy in a 1:1 ratio. For the restrictive-fluid group, IV fluid could only be given to correct severe hypoperfusion, replace documented fluid loss such as gastrointestinal or drain losses, maintain a daily fluid intake of one liter, or for patients with contraindication for oral fluid intake. Patients were followed for 90 days after enrolling in the study. Patients remained in the ICU for a median of 5 days (interquartile ranges, 3 to 9 days for restrictive-fluid patients and 3 to 10 days for standard-fluid patients). The restrictive- and standard-fluid groups received a median of 1798mL and 3811mL of IV fluids, respectively. There was no significant difference in mortality between the restrictive- (42.3%) and standard-fluid (42.1%) groups. Similarly, no differences between the two groups were found in survival durations without life support or after hospital discharge. There was also no significant difference in the incidence of serious adverse events in the restrictive- (29.4%) and standard-fluid (30.8%) groups. Severe adverse events included cerebral, cardiac, intestinal, or limb ischemic events. In summary, the results from this study may support new guidelines for fluid management for ICU patients with septic shock.

Image: PD

RELATED REPORTS

High emergency department pediatric readiness associated with decreased mortality

2 Minute Medicine Rewind January 16, 2023

Clinical decision-making strategy improves acute heart failure outcomes

©2022 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

 

Tags: emergencyfluid restrictionICUinfectious diseaseintensive care unitintravenous fluidssepsisseptic shock
Previous Post

Intravenous vitamin C increases mortality and organ dysfunction in sepsis patients

Next Post

#VisualAbstract: Varenicline improves successful smoking cessation amongst African American daily smokers: KIS-IV Trial

RelatedReports

Quick Take: Impact of scribes on emergency medicine doctors’ productivity and patient throughput: multicentre randomised trial
Emergency

High emergency department pediatric readiness associated with decreased mortality

January 16, 2023
Compliance-linked incentives increase infant immunizations rates in rural India
Weekly Rewinds

2 Minute Medicine Rewind January 16, 2023

January 16, 2023
Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial
Cardiology

Clinical decision-making strategy improves acute heart failure outcomes

January 12, 2023
Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Emergency

Higher rate of adverse events following abortion induced by mifepristone-misoprostol than procedurally

January 10, 2023
Next Post
#VisualAbstract: Varenicline improves successful smoking cessation amongst African American daily smokers: KIS-IV Trial

#VisualAbstract: Varenicline improves successful smoking cessation amongst African American daily smokers: KIS-IV Trial

Improved glycemic control in type 1 diabetics on very low-carbohydrate diets

Improved diet quality may be associated with increased longevity and better aging in Israeli adults

Smoking during pregnancy associated with aerobic fitness of children

Heavy smoking is associated with visual field loss in glaucoma

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab reduce postmenopausal fracture risk
  • Epstein-Barr viral load monitoring reduces risk of post-liver transplant lymphoproliferative disease
  • Homicide deaths are on the rise for children living in the United States
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options